PharmaResources (Shanghai) Co. Ltd. A Cash Flow Quality Index
PharmaResources (Shanghai) Co. Ltd. A cash flow quality index. PharmaResources (Shanghai) Co. Ltd. A (301230) has a Cash Flow Quality Index of 3.95x as of December 2025. Operating cash flow of CN¥135.51 Million exceeds net income of CN¥34.29 Million, indicating high earnings quality where cash backs reported profits. See PharmaResources (Shanghai) Co. Ltd. A (301230) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Cash flow quality index of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. Historical Cash Flow Quality Index for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore PharmaResources (Shanghai) Co. Ltd. A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
PharmaResources (Shanghai) Co. Ltd. A Cash Flow Quality Index by Year (2020–2025)
PharmaResources (Shanghai) Co. Ltd. A cash flow quality index by year from 2020 to 2025. Year-by-year earnings quality comparison for PharmaResources (Shanghai) Co. Ltd. A. For the full cash flow conversion analysis, see 301230 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.95x | CN¥135.51 Million | CN¥34.29 Million | ▼ -16.5% |
| 2024 | 4.73x | CN¥80.86 Million | CN¥17.08 Million | ▲ +753.7% |
| 2023 | 0.55x | CN¥20.86 Million | CN¥37.62 Million | ▼ -62.5% |
| 2022 | 1.48x | CN¥99.29 Million | CN¥67.18 Million | ▲ +3.5% |
| 2021 | 1.43x | CN¥105.12 Million | CN¥73.58 Million | ▲ +27.8% |
| 2020 | 1.12x | CN¥54.45 Million | CN¥48.69 Million | — |